Table 3. Normalisation process theory constructs mapped to the identified themes.

COHERENCE. Sense-making work: How pharmacists and GP staff understood and attributed worth to the intervention.	COGNITIVE PARTICIPATION. Relational work that people did to set up and establish the intervention; enrolment, engagement and buy-in
The dashboard was perceived as easy to use Pharmacists considered the dashboard added value to their work The intervention was perceived to be embedded in the context of wider medicines safety activities. Pharmacists were largely responsible for integrating it into the GP practice. Pharmacists considered that they overcame resistance to the intervention through sense-making work with other practice staff.	Collaborations established the intervention with pharmacists leading this by demonstrating the dashboard to others within the practice. There was varied access and engagement from different stakeholders Pharmacists felt that trust and confidence in the dashboard and in the work of the pharmacists highlighting hazardous prescribing and initiating changes to patient’s medication was important in establishing the intervention.
COLLECTIVE ACTION. The work undertaken to sustain and operationalise the intervention: interactions, relationships and collaborations.	REFLEXIVE MONITORING. Appraising and monitoring: how pharmacists and clinicians reflected upon and appraised the intervention
Communication and collaboration was seen as important Collaborations between pharmacists and prescribers were based upon agreement and planning. The dashboard was perceived to help to build relationships.	Pharmacists met together and gave feedback to the research team which led to developments in the dashboard. The intervention was seen as a tool that could lead to changes in work practices Pharmacists broadened their actions from attending to high risk prescribing cases to undertaking full medicine reviews with patients. Education and development important to the intervention The dashboard was seen as presenting opportunities for further medicines safety activities.